Human IgE is efficiently produced in glycosylated and biologically active form in lepidopteran cells
Authors:
- 1 April 2016
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 72, 49-56
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Lepidopteran cells, an alternative for the production of recombinant antibodies?mAbs, 2012
- Allergic host defencesNature, 2012
- Generation and epitope analysis of human monoclonal antibody isotypes with specificity for the timothy grass major allergen Phl p 5aMolecular Immunology, 2011
- Dissecting cross-reactivity in hymenoptera venom allergy by circumvention of α-1,3-core fucosylationMolecular Immunology, 2010
- Galectin-9 Is a High Affinity IgE-binding Lectin with Anti-allergic Effect by Blocking IgE-Antigen Complex FormationJournal of Biological Chemistry, 2009
- Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cellsCancer Immunology, Immunotherapy, 2008
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-GalactoseNew England Journal of Medicine, 2008
- Affinity of IgE and IgG against cross-reactive carbohydrate determinants on plant and insect glycoproteinsJournal of Allergy and Clinical Immunology, 2008
- Structure of the Human IgE-Fc Cε3-Cε4 Reveals Conformational Flexibility in the Antibody Effector DomainsImmunity, 2000
- Characterisation of recombinant human IgE-Fc fragments expressed in baculovirus-infected insect cellsMolecular Immunology, 2000